drugset / Trial / NCT01694576

NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

NCT01694576

Phase 2 Terminated 10 enrolled Jiangsu Cancer Institute & Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

By this clinical trial, the investigators are trying to give an answer to such a question. Whether NPC patients staged N2-3M0 need adjuvant chemotherapy consisting of paclitaxel and platinum after concurrent chemoradiation?

Timeline

Start
2012-09
Primary completion
2015-09
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nedaplatin Small molecule
Subject Paclitaxel Small molecule